申请人:Nippon Soda Co., Ltd.
公开号:US06342516B1
公开(公告)日:2002-01-29
Phenylazole compounds represented by general formula (1) or pharmaceutically acceptable salts thereof and drugs for hyperlipemia which contain these compounds as the active ingredient, wherein A represents imidazolyl, pyrazolyl, etc.; B represents (1a) or (1b) (wherein R2 and R3 represent each hydrogen, C1-6 alkyl, etc; and k is 0 or an integer of 1 to 15); Y represents O, S, a bond, etc.; and Z represents an optionally substituted and saturated or unsaturated heterocycle containing 1 to 4 N, O or S atoms. Among all, compounds wherein Z is substituted chroman-2-yl, 2,3-dihydrobenzofuran-2-yl, etc. have an effect of inhibiting the formation of lipid peroxides too.
通用公式(1)所代表的苯唑化合物或其药用盐,以及作为活性成分含有这些化合物的高脂血症药物,其中A代表咪唑基,吡唑基等;B代表(1a)或(1b)(其中R2和R3分别代表氢,C1-6烷基等;k为0或1至15的整数);Y代表O,S,键等;Z代表含有1至4个N、O或S原子的可选择取代的饱和或不饱和杂环。在所有化合物中,其中Z为取代的色甘酮-2-基,2,3-二氢苯并呋喃-2-基等,也具有抑制脂质过氧化物形成的作用。